The AR Lab Network was established in 2016 to help identify, respond to, and prevent antibiotic resistance in the United States. As a Regional Lab, the WSLH performs comprehensive testing on antimicrobial resistant organisms for the state of Wisconsin, as well as select testing for other states in the Midwest Region of the AR Lab Network: Kentucky, Illinois, Indiana, Michigan, and Ohio.
Candida glabrata from normally sterile sites (including serial glabrata isolates from patients receiving antifungal treatment
Multi-drug resistant Candida isolates
Unusual Candida species (any species other than albicans, C. parapsilosis, C. dubliniensis, C. lusitaniae, C. tropicalis, C. krusei)
Any Candida species that was unable to be identified after a validated method was attempted
WSLH Testing Methodology
Species identification using MALDI-TOF mass spectrometry
Antifungal susceptibility testing via broth microdilution (azoles and echinocandins)
Amphotericin B susceptibility testing using Etest strips
Testing performed for surveillance. MIC results provided upon request.
Turnaround Time
1 week for species identification
Contact
Ann Valley, 608-224-4246
Notifiable Conditions Information
Candida auris is a reportable condition in Wisconsin under the provision for ‘Any detection of, or illness caused by, an agent that is foreign, exotic or unusual to Wisconsin, and that has public health implications’ in Chapter DHS 145.
Please report any confirmed cases to the Local Health Department and the Wisconsin HAI Program at 608-266-0915 or 608-267-7711
Include copy of susceptibility results performed in your laboratory
Part of ARLN’s targeted surveillance project
Pre-approval required?
Acinetobacter baumannii is not included in state-wide surveillance. WSLH solicits isolates from southeast WI as part of a targeted surveillance program.
If you have isolates that have been deemed highly resistant at the clinical lab or are suspected of being part of an outbreak and are not located in SE WI, contact WSLH for guidance on submission.
Isolates Accepted
Acinetobacter baumannii isolates resistant to any carbapenem (doripenem, imipenem, meropenem)
WSLH Testing Methodology
Species identification using MALDI-TOF mass spectrometry
Antibiotic susceptibility testing via broth microdilution
Test non-susceptible to all beta-lactams, including either ceftazidime-avibactam or meropenem-vaborbactam.
-OR-
Enterobacteriaceae possessing NDM, VIM, or IMP genes confirmed by a molecular test and are highly resistant to all or the majority of antimicrobial agents already tested.
WSLH Testing Methodology
Antibiotic susceptibility testing via broth microdilution